Pharma Industry News

NICE approves Merck’s Keytruda for adult patients with rare triple negative breast cancer

The injection is given in combination with chemotherapy and administered once every three weeksOriginal Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]